Studies on PPARγ signal pathway of conjugated linoleic acid isomers induce apoptosis of human breast cancer cell line SKBr3

Progress in Biochemistry and Biophysics

Volumn 36, Issue 4, 2009, Pages 491-499

  Yuan, Xian Lin ^b   He, Feng ^a   Chen, Qing ^a   Yang, Xiang Ling ^a   Yang, De Po ^a   Wang, Dong Mei ^a   Zhong, Ling ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b TCM Hospital of Guangzhou   (China)

Author keywords

Apoptosis; Conjugated linoleic acid isomer; Human breast cancer cell line SKBR3; Peroxisome proliferators activated receptor (PPAR )

Indexed keywords

EID: 68049144907     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: 10.3724/SPJ.1206.2008.00549     Document Type: Article

References (21)

1. Ha Y L, Storkson J, Pariza M W. Inhibition of benzo (a) pyrene-induced mouse forestomach neoplasia by conjugated dienoic derivatives of linoleic acid. Cancer Res, 1990, 50(4): 1097̃1101
2. Schonberg S, Krokan H E. The inhibitory effect of conjugated dienoic derivatives (CLA) of linoleic acid on the growth of human tumor cell lines in part due to increased lipid peroxidation. Anticancer Res, 1995,15(4): 1241̃1246
3. Cho H J, Kim E J, Lim S S, et al. Trans-10, cis-12, not cis-9, trans-11, conjugated linoleic acid inhibits G1-S progression in HT-29 human colon cancer cells. J Nutr, 2006,136(4): 893̃898
4. Bocca C, Bozzo F, Gabriel L, et al. Conjugated linoleic acid inhibits Caco-2 cell growth via ERK-MAPK signaling pathway. J Nutr Biochem, 2007,18(5): 332̃340
5. Wang L S, Huang Y W, Sugimoto Y, et al. Effects of human breast stroma cell on conjugated linoleic acid (CLA) modulated vascular endothelial growth factor-A (VEGF-A) expression in MCF-7 cell. AnticancerRes, 2005,25(6B): 4061̃4068
6. Bocca C, Bozzo F, Francica S, et al. Involvement of PPAR7 and E-cadherin/β-catenin pathway in the antiproliferative effect of conjugated linoleic acid in MCF-7 cells. Int J Cancer, 2007,121(2): 248̃256
7. O'Shea M, Devery R, Lawless F, et al. Milk fat conjugated linoleic acid (CLA) inhibits growth of human mammary MCF-7 cancer cells. AnticancerRes, 2000,20(5B): 3591̃3601
8. Majumder B, Wahle K W, Moir S, et al. Conjugated linoleic acids (CLAs) regulate the expression of key apoptotic genes in human breast cancer cells. The FASEB J, 2002,16(11): 1447̃1449
9. Wongtangtintharn S, Oku H, Iwasaki H, et al. Incorporation of branched-chain fatty acid into cellular lipids and caspase-independent apoptosis in human breast cancer cell line, SKBR-3. Lipids in Health and Disease, 2005,4: 29
10. Pariza M W, Loretz L J, Storkson J M, et al. Mutagens and modulator of mutagenesis in fried ground beef. Cancer Res, 1983, 43 (5 Suppl.): 2444s̃2446s
11. Ip C, Ip M M, Loftus T, et al. Induction of apoptosis by conjugated linoleic acid in cultured mammary tumor cells and premalignant lesions of the rat mammary gland. Cancer Epidemiol Biomarkers Prev, 2000,9 (7): 689̃696
12. Sato T, Hanada M, Bodrug S, et al. Interactions among members of the Bcl-2 protein family analyzed with a yeast two-hybrid system. Proc Natl Acad Sci USA, 1994,91 (20): 9238̃9242
13. Fenner M H, Elster E. Peroxisome proliferator-activated receptor-γ ligands for the treatment of breast cancer. Expert Opin Investing Drugs, 2005,14(6): 557̃568
14. Kubota N, Terauchi Y, Miki H, et al. PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell, 1999,4(4): 597̃609
15. Barak Y, Nelson M C, Ong E S, et al. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell, 1999, 4(4): 585̃595
16. Vamecq J, Latruffe N. Medical significance of peroxisome proliferentiator-activated receptors. Lancet, 1999,354(9173): 141̃148
17. Pighetti G M, Novosad W, Nicholson C, et al. Theraputic treatment of DMBA-induced mammary tumors with PPAR ligands. AnticancerRes,2001, 21(2A): 825̃830
18. Nolte R T, Wisely G B, Westin S, et al. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-Gamma. Nature, 1998,395(6698): 137̃143
19. Kotani T, Yamashita M. Discrimination of the roles of MPF and MAP kinase in morphological changes that occur during oocyte maturation. Dev Biol, 2002,252(2): 271̃286
20. Willson T M, Brown P J, Sternbach D D, et al. The ppars: from orphan receptors to drug discovery. J Med Chem, 2000, 43 (4): 527̃550
21. Tzameli I, Fang H, Ollero M, et al. Regulated production of a PPARgamma ligand during an early phase of adipocyte differentiation in 3T3-L1 adipocytes. J Biol Chem, 2004, 279(34): 36093̃36102